Henan Lingrui Pharmaceutical Co., Ltd. (SHA: 600285)

Henan Lingrui Pharmaceutical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 5, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	12,885	9,649	7,358	8,920	4,809	5,621
Market Cap Growth	50.70%	31.14%	-17.51%	85.47%	-14.44%	27.46%
Enterprise Value	12,069	8,482	6,324	8,108	4,064	5,063
Last Close Price	22.88	16.56	12.16	14.15	7.29	8.24
PE Ratio	19.48	16.51	14.84	22.18	12.72	16.09
PS Ratio	3.66	2.91	2.45	3.31	2.06	2.61
PB Ratio	4.77	3.45	2.88	3.90	2.07	2.53
P/FCF Ratio	18.90	12.18	9.11	11.60	12.70	14.37
P/OCF Ratio	19.21	11.86	8.81	10.55	10.67	12.49
EV/Sales Ratio	3.43	2.56	2.11	3.01	1.74	2.35
EV/EBITDA Ratio	15.78	12.76	13.65	18.11	10.57	12.78
EV/EBIT Ratio	17.50	14.40	16.25	21.54	12.85	15.40
EV/FCF Ratio	17.71	10.71	7.83	10.55	10.73	12.95
Debt / Equity Ratio	0.03	0.07	0.06	0.12	0.07	0.13
Debt / EBITDA Ratio	0.11	0.31	0.34	0.63	0.43	0.71
Debt / FCF Ratio	0.12	0.26	0.20	0.37	0.44	0.72
Asset Turnover	0.78	0.73	0.74	0.74	0.69	0.67
Inventory Turnover	2.07	1.86	1.83	1.86	1.77	1.62
Quick Ratio	0.84	1.11	1.16	1.16	1.45	1.41
Current Ratio	1.08	1.37	1.47	1.48	1.80	1.73
Return on Equity (ROE)	25.25%	21.21%	19.21%	15.73%	14.28%	13.59%
Return on Assets (ROA)	9.51%	8.07%	5.98%	6.49%	5.84%	6.39%
Return on Capital (ROIC)	15.73%	12.86%	9.20%	9.31%	7.92%	8.43%
Earnings Yield	5.13%	5.89%	6.32%	4.05%	6.77%	5.24%
FCF Yield	5.29%	8.21%	10.98%	8.62%	7.87%	6.96%
Dividend Yield	3.50%	4.83%	4.94%	3.53%	5.49%	3.64%
Payout Ratio	68.96%	60.60%	62.08%	61.91%	55.03%	33.39%
Buyback Yield / Dilution	-0.01%	0.30%	-0.26%	0.24%	1.22%	2.60%
Total Shareholder Return	3.49%	5.13%	4.68%	3.77%	6.71%	6.25%

Source: S&P Capital IQ. Standard template. Financial Sources.